Life Science Leader Blogs

  1. Are You Ready For BIO 2018 In Boston?

    Tips to help you get ready for the 2018 BIO International Convention in Boston, June 4 - 7.

  2. Is The Open Office Concept An Idea That Should Have Been Killed?

    Rob Wright discusses the open office concept, and if it is an idea that should be killed.

  3. A Testament To Biopharma’s Transparent Leaders: And A Previously Unpublished Regeneron Article Sidebar

    Rob Wright discusses the unusual genesis of the Regeneron Genetics Center (RGC).

  4. 4 Can’t-Miss Educational Sessions At BIO 2018

    Rob Wright lists four can’t miss educational sessions for this year’s annual BIO International Convention in Boston.

  5. My 10 Favorite Quotes From George Yancopoulos

    My 10 favorite quotes from interviewing George Yancopoulos, M.D., Ph.D., president and chief scientific officer at Regeneron Pharmaceuticals.

  6. How Can The Pharma Industry Help The Homeless?

    Readers provide feedback and suggestions around how the biopharmaceutical industry could help the homeless during the annual J.P. Morgan Healthcare Conference in San Francisco.

  7. The R&D Leadership Summit 2018 — One Hot Ticket

    The Conference Forum’s 2018 R&D Leadership Summit employs the Chatham House Rule, which limits what information can be revealed from the event's proceedings. As one of the only members of the media in the room, Chief Editor Rob Wright shares what he can from this year's event, which had the theme “Growth: Where Will It Come From?”

  8. Your Bio Company’s Story: The Mechanics Of Clarity

    Here, I aim to offer some additional ideas for how companies can best describe themselves and their products — and how PR agents, journalists, and others might describe them — by achieving the opposite of hype: clarity.

  9. J&J’s Addition Of JLABS in New York City Creates Buzz At BIO CEO 2018

    Rob Wright interviews Kate Merton, head of Johnson & Johnson Innovation’s newly created JLABS in New York City.

  10. Jeremy Levin On BIO’s Efforts Toward Tackling The Opioid Crisis

    Rob Wright interviews Jeremy Levin, chairman and CEO of Ovid Therapeutics, about the BIO opioid crisis working group he is chairing.